Baxter GamCath Dolphin Protect Catheter Kit

The GamCath Dolphin Protect is a specialized medical device used primarily in hemodialysis and specialty medicine. This specific line of catheters, featuring the 'Dolphin Protect' antimicrobial coating, was developed to minimize infection risks during long-term vascular access.

Originally developed by Gambit-GmbH (which became part of Gambro), the brand entered the portfolio of Baxter International Inc. when Baxter acquired Gambro in 2013 for approximately $4 billion. This acquisition was a strategic move to solidify Baxter's position in the global renal care and hemodialysis market. While Baxter is an American healthcare giant, this specific product line continues to be manufactured in Germany, maintaining the engineering standards established by its original European developers. Today, Baxter operates as a global leader in medical supplies, with its products found in hospitals and clinics worldwide.